News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

On January 23, NIH and FNIH leaders will hold a RECOVER-TLC webinar to provide updates and answer questions about RECOVER’s latest clinical trial efforts.
A network of 42 RECOVER sites across the US worked to reach out to potential study participants, communicate with the trial team, and reach the trials’ enrollment goal 2 months ahead of schedule.
Feedback from patients, caregivers, and others will help shape studies testing the safety and effectiveness of potential Long COVID treatments.
Results from the RECOVER-NEURO clinical trial were published in the journal JAMA Neurology. The trial focused on symptoms of cognitive dysfunction associated with Long COVID, including brain fog, trouble focusing, and thinking clearly.
Teams from 4 RECOVER clinical trial sites share their recruitment strategies and their efforts to reach out to and share research opportunities with their local communities.
RECOVER Representatives use their lived experience and feedback from their communities to make recommendations that help make RECOVER-SLEEP trial participation simpler and more accessible.
NIH leaders and RECOVER researchers will provide updates on RECOVER-Treating Long COVID (RECOVER-TLC), the next phase of RECOVER Long COVID clinical trials.
Leveraging staff expertise and consistent monitoring, a RECOVER-ENERGIZE clinical trial is exploring whether a personalized cardiopulmonary rehabilitation program can help people with Long COVID regain physical activity.